OMNI 360 Wealth Inc. Takes Position in CME Group Inc. (NASDAQ:CME)

OMNI 360 Wealth Inc. purchased a new stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 1,382 shares of the financial services provider's stock, valued at approximately $367,000.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Heartland Bank & Trust Co purchased a new stake in shares of CME Group during the 1st quarter worth approximately $377,000. Catalyst Capital Advisors LLC grew its holdings in CME Group by 256.9% during the first quarter. Catalyst Capital Advisors LLC now owns 3,662 shares of the financial services provider's stock valued at $971,000 after purchasing an additional 2,636 shares during the period. Aspire Growth Partners LLC bought a new position in CME Group during the fourth quarter valued at $548,000. First Citizens Bank & Trust Co. increased its position in CME Group by 3.4% in the first quarter. First Citizens Bank & Trust Co. now owns 43,135 shares of the financial services provider's stock worth $11,443,000 after buying an additional 1,408 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC raised its stake in shares of CME Group by 63.0% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 105,044 shares of the financial services provider's stock valued at $27,867,000 after buying an additional 40,592 shares during the period. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on CME. Piper Sandler increased their price target on CME Group from $275.00 to $283.00 and gave the stock an "overweight" rating in a research note on Tuesday, April 8th. Wall Street Zen raised shares of CME Group from a "sell" rating to a "hold" rating in a report on Saturday. Citigroup lifted their target price on shares of CME Group from $265.00 to $275.00 and gave the stock a "neutral" rating in a research note on Thursday, July 3rd. Keefe, Bruyette & Woods boosted their price target on shares of CME Group from $265.00 to $273.00 and gave the company a "market perform" rating in a research report on Thursday, April 24th. Finally, Morgan Stanley raised their price objective on shares of CME Group from $301.00 to $304.00 and gave the stock an "overweight" rating in a report on Thursday, April 24th. Three research analysts have rated the stock with a sell rating, nine have given a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $259.87.

CME Group Price Performance

NASDAQ:CME traded up $0.01 during trading hours on Wednesday, hitting $275.64. 2,841,477 shares of the company's stock traded hands, compared to its average volume of 2,198,338. CME Group Inc. has a 52 week low of $193.17 and a 52 week high of $290.79. The business's fifty day simple moving average is $276.76 and its two-hundred day simple moving average is $258.61. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The firm has a market cap of $99.33 billion, a P/E ratio of 27.73, a P/E/G ratio of 3.74 and a beta of 0.44.

CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.61 by $0.19. The firm had revenue of $1.64 billion during the quarter, compared to the consensus estimate of $1.56 billion. CME Group had a return on equity of 14.03% and a net margin of 57.71%. The company's revenue for the quarter was up 10.4% on a year-over-year basis. During the same quarter last year, the company posted $2.50 EPS. On average, research analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th were paid a $1.25 dividend. The ex-dividend date of this dividend was Monday, June 9th. This represents a $5.00 dividend on an annualized basis and a yield of 1.81%. CME Group's dividend payout ratio is presently 50.30%.

Insider Transactions at CME Group

In related news, Director Phyllis M. Lockett sold 1,060 shares of the firm's stock in a transaction dated Monday, May 19th. The stock was sold at an average price of $277.88, for a total transaction of $294,552.80. Following the transaction, the director directly owned 3,108 shares of the company's stock, valued at approximately $863,651.04. This trade represents a 25.43% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Larry G. Gerdes sold 2,000 shares of the business's stock in a transaction that occurred on Thursday, April 24th. The stock was sold at an average price of $264.10, for a total value of $528,200.00. Following the completion of the sale, the director owned 38,651 shares of the company's stock, valued at $10,207,729.10. The trade was a 4.92% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 13,400 shares of company stock worth $3,680,610. Company insiders own 0.30% of the company's stock.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.